Northern Trust Corp Sarepta Therapeutics, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 655,637 shares of SRPT stock, worth $73.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

655,637

Previous 668,078 1.86%

Holding current value

$73.3 Million

Previous $106 Million 22.42%

% of portfolio

0.01%

Previous 0.02%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$124.33 - $156.75 $1.55 Million - $1.95 Million	-12,441 Reduced 1.86%	655,637 $81.9 Million
Q2 2024 Aug 14, 2024	BUY	$113.33 - $163.85 $26.9 Million - $38.9 Million	237,255 Added 55.07%	668,078 $106 Million
Q1 2024 May 14, 2024	SELL	$93.7 - $141.53 $631,819 - $954,336	-6,743 Reduced 1.54%	430,823 $55.8 Million
Q4 2023 Feb 13, 2024	BUY	$67.31 - $124.76 $817,345 - $1.51 Million	12,143 Added 2.85%	437,566 $42.2 Million
Q3 2023 Nov 13, 2023	BUY	$102.5 - $123.59 $1.52 Million - $1.84 Million	14,868 Added 3.62%	425,423 $51.6 Million
Q2 2023 Aug 11, 2023	BUY	$106.4 - $157.19 $1.08 Million - $1.59 Million	10,136 Added 2.53%	410,555 $47 Million
Q1 2023 May 15, 2023	BUY	$117.53 - $155.99 $1.03 Million - $1.37 Million	8,793 Added 2.25%	400,419 $55.2 Million
Q4 2022 Feb 13, 2023	BUY	$100.86 - $132.13 $612,522 - $802,425	6,073 Added 1.58%	391,626 $50.7 Million
Q3 2022 Nov 14, 2022	BUY	$75.71 - $119.24 $191,243 - $301,200	2,526 Added 0.66%	385,553 $42.6 Million
Q2 2022 Aug 12, 2022	SELL	$62.69 - $88.44 $1.1 Million - $1.56 Million	-17,599 Reduced 4.39%	383,027 $28.7 Million
Q1 2022 May 13, 2022	SELL	$63.15 - $90.42 $350,166 - $501,378	-5,545 Reduced 1.37%	400,626 $31.3 Million
Q4 2021 Feb 08, 2022	BUY	$77.28 - $99.42 $1.06 Million - $1.37 Million	13,744 Added 3.5%	406,171 $36.6 Million
Q3 2021 Nov 15, 2021	BUY	$65.97 - $92.48 $278,195 - $389,988	4,217 Added 1.09%	392,427 $36.3 Million
Q2 2021 Aug 13, 2021	SELL	$69.38 - $86.75 $6.56 Million - $8.21 Million	-94,592 Reduced 19.59%	388,210 $30.2 Million
Q1 2021 May 12, 2021	SELL	$72.25 - $168.95 $577,638 - $1.35 Million	-7,995 Reduced 1.63%	482,802 $36 Million
Q4 2020 Feb 11, 2021	BUY	$125.56 - $178.74 $335,496 - $477,593	2,672 Added 0.55%	490,797 $83.7 Million
Q3 2020 Nov 16, 2020	BUY	$127.12 - $172.34 $1.4 Million - $1.89 Million	10,982 Added 2.3%	488,125 $68.5 Million
Q2 2020 Aug 14, 2020	BUY	$93.0 - $171.7 $1.52 Million - $2.8 Million	16,316 Added 3.54%	477,143 $76.5 Million
Q1 2020 May 14, 2020	BUY	$82.38 - $131.64 $1.85 Million - $2.96 Million	22,486 Added 5.13%	460,827 $45.1 Million
Q4 2019 Feb 14, 2020	BUY	$76.53 - $135.58 $199,437 - $353,321	2,606 Added 0.6%	438,341 $56.6 Million
Q3 2019 Nov 13, 2019	BUY	$72.81 - $156.91 $7.29 Million - $15.7 Million	100,157 Added 29.85%	435,735 $32.8 Million
Q2 2019 Aug 13, 2019	BUY	$112.21 - $151.95 $2.57 Million - $3.48 Million	22,903 Added 7.32%	335,578 $51 Million
Q1 2019 May 13, 2019	SELL	$106.67 - $151.68 $598,632 - $851,228	-5,612 Reduced 1.76%	312,675 $37.3 Million
Q4 2018 Feb 12, 2019	BUY	$97.32 - $148.76 $1.9 Million - $2.9 Million	19,473 Added 6.52%	318,287 $34.7 Million
Q3 2018 Nov 14, 2018	BUY	$115.31 - $161.51 $72,299 - $101,266	627 Added 0.21%	298,814 $48.3 Million
Q2 2018 Sep 18, 2018	SELL	$71.74 - $153.69 $289,614 - $620,446	-4,037 Reduced 1.34%	298,187 $39.4 Million
Q2 2018 Aug 14, 2018	SELL	$71.74 - $153.69 $29.5 Million - $63.2 Million	-411,535 Reduced 57.66%	302,224 $39.9 Million
Q1 2018 May 09, 2018	SELL	$54.02 - $82.27 $22,310 - $33,977	-413 Reduced 0.06%	713,759 $52.9 Million
Q4 2017 Feb 14, 2018	BUY	$47.64 - $56.75 $168,169 - $200,327	3,530 Added 0.5%	714,172 $39.7 Million
Q3 2017 Nov 13, 2017	BUY	$35.73 - $47.15 $25.4 Million - $33.5 Million	710,642	710,642 $32.2 Million

Others Institutions Holding SRPT

# of Institutions

528

Shares Held

85M

Call Options Held

2.06M

Put Options Held

1.52M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $9.79B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Sarepta Therapeutics, Inc. Transaction History